A detailed history of Harbor Advisory Corp transactions in Pfizer Inc stock. As of the latest transaction made, Harbor Advisory Corp holds 122,632 shares of PFE stock, worth $3.59 Million. This represents 1.19% of its overall portfolio holdings.

Number of Shares
122,632
Previous 123,365 0.59%
Holding current value
$3.59 Million
Previous $3.42 Million 0.23%
% of portfolio
1.19%
Previous 1.17%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 25, 2024

SELL
$25.26 - $29.6 $18,515 - $21,696
-733 Reduced 0.59%
122,632 $3.43 Million
Q1 2024

Apr 29, 2024

BUY
$25.89 - $29.73 $5,618 - $6,451
217 Added 0.18%
123,365 $3.42 Million
Q4 2023

Feb 05, 2024

BUY
$26.13 - $33.94 $388,579 - $504,721
14,871 Added 13.73%
123,148 $3.55 Million
Q3 2023

Oct 27, 2023

BUY
$32.09 - $37.51 $54,071 - $63,204
1,685 Added 1.58%
108,277 $3.59 Million
Q2 2023

Aug 03, 2023

BUY
$36.12 - $41.79 $66,858 - $77,353
1,851 Added 1.77%
106,592 $3.91 Million
Q1 2023

May 04, 2023

BUY
$39.39 - $51.28 $50,379 - $65,587
1,279 Added 1.24%
104,741 $4.27 Million
Q4 2022

Feb 07, 2023

BUY
$41.75 - $54.5 $112,725 - $147,150
2,700 Added 2.68%
103,462 $5.3 Million
Q3 2022

Oct 31, 2022

BUY
$43.76 - $53.42 $231,227 - $282,271
5,284 Added 5.53%
100,762 $4.41 Million
Q2 2022

Aug 01, 2022

BUY
$46.53 - $55.17 $482,562 - $572,168
10,371 Added 12.19%
95,478 $5.01 Million
Q1 2022

May 13, 2022

SELL
$45.75 - $56.69 $137,250 - $170,070
-3,000 Reduced 3.4%
85,107 $4.41 Million
Q4 2021

Feb 07, 2022

BUY
$41.32 - $61.25 $310,933 - $460,906
7,525 Added 9.34%
88,107 $5.2 Million
Q3 2021

Nov 12, 2021

BUY
$39.25 - $50.42 $208,025 - $267,226
5,300 Added 7.04%
80,582 $3.47 Million
Q2 2021

Aug 04, 2021

BUY
$35.91 - $40.68 $2.7 Million - $3.06 Million
75,282 New
75,282 $2.95 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $164B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Harbor Advisory Corp Portfolio

Follow Harbor Advisory Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Harbor Advisory Corp , based on Form 13F filings with the SEC.

News

Stay updated on Harbor Advisory Corp with notifications on news.